Baltimore, Maryland
Julius H. Jacobson II, Professor of Surgery
The Johns Hopkins University School of Medicine
Vice Chair of Clinical Operations
Department of Surgery
Chief Emeritus, Division of Vascular Surgery
The Johns Hopkins Hospital
SCHEDULE FOR VEITHsymposium™
Tuesday, November 15, 2022
Presenter
SESSION 10: NEW DEVELOPMENTS IN CAROTID DISEASE AND ITS TREATMENT; DIFFERING VIEWS ON TREATMENT OF ASYMPTOMATIC CAROTID STENOSIS (ACS) AND CAROTID SCREENING
DEBATE: Not So: About 25% Of ACS Patients Can Benefit From CEA Or CAS And Should Be So Treated
8:26 AM - 8:31 AM

Power Point Presentation with Synched Audio

View Slides in PDF
Wednesday, November 16, 2022
Presenter
SESSION 38: UPDATES AND ISSUES IMPORTANT TO ALL VASCULAR SURGEONS AND SPECIALISTS: FUTURE REIMBURSEMENT; ETHICS OF FDA ACCESS; VASCULAR REGISTRIES AND THE VQI, VALUE OF GUIDELINES, ENDPOINTS; INDUSTRY RELATIONS; IMPACT OF GOVERNMENT (ACA) AND REGULATORY AGENCIES (FDA)
Despite What The New York Times And Others Say, Close Relationships Of Vascular Surgeons With Industry Are Mostly Ethical And Beneficial To Patients And Society: Pitfalls To Avoid
4:55 PM - 5:00 PM

Power Point Presentation with Synched Audio

View Slides in PDF
Friday, November 18, 2022
Presenter
SESSION 79: MORE CAROTID NEW DEVELOPMENT TOPICS RELATED TO TCAR, NEW DEVICES, MESH COVERED STENTS, MINI-INCISION CEA, TIMING OF TREATMENT, MEDICAL TREATMENT AND DEALING WITH DISTAL (HIGH) CAROTID LESIONS
Is TCAR Yet Ready To Replace CEA: Not So Fast: We Still Need Further Proof And More Studies Including An RCT
10:36 AM - 10:41 AM

Power Point Presentation with Synched Audio

View Slides in PDF
 
previous next